mitosis and cytokinesis (cell division) in the M phase is accumulating that directly responsible for the rate of progres- (Fig. 1) .
sion of glomerular disease are specific positive (cyclins and Second, the original view that the cell cycle only govcyclin-dependent kinases) and negative (cyclin-kinase inhibierns cell proliferation is no longer valid because under tors) cell cycle regulatory proteins. The challenge for nephrolocertain circumstances, arrest in or exit from the cell cycle gists is to determine which ones are expressed in renal disease results in different types of growth ( Fig. 1) . Thus, arrest and their precise role in glomerular cell proliferation, hypertroin G 1 is associated with hypertrophy [3] . Exit from the phy and differentiation. Ultimately the goal is to find ever cell cycle in late G 1 leads to apoptosis [4] , and the promore appropriate therapeutic strategies to arrest or prevent progressive renal disease.
grammed exit from the cell cycle at G 2 /M is associated with cell differentiation [5] .
Third, each phase of the cell cycle is controlled by specific positive [cyclins and cyclin-dependent kinases There are many forms of glomerular growth that char-(CDKs)] [6, 7] and negative (cyclin-kinase inhibitors) cell acterize different types of glomerular diseases, and these cycle regulatory proteins ( Fig. 2) [8]. Detailed reviews of include proliferation, hypertrophy, and differentiation.
cell cycle proteins has been presented by others at this As is discussed later in this article, each type of glomerusymposium and in other reviews. In brief, progression lar growth underlies the development of progressive glothrough or arrest during the cell cycle is controlled by merulosclerosis, and thus, as nephrologists, it is of fundacell cycle regulatory proteins. Proliferation (completion mental importance that we understand and can intervene of the cell cycle) requires that cyclins bind to and activate with these processes to reduce progressive disease. There specific CDKs in each phase of the cell cycle (Fig. 2) . are multiple potential mediators of glomerular growth,
In contrast, the inhibition of cyclin-CDK complexes by such as growth factors and their receptors, signaling pathcyclin-kinase inhibitors inhibits proliferation by causing ways, and transcription factors. However, there is incell cycle arrest. The study of cell cycle regulatory proteins in glomerucreasing evidence to show that regulation of the cell cycle lar disease poses a number of interesting challenges for by cell cycle regulatory proteins, which are predominephrologists. These include determining: (a) which spenantly located in the nucleus, ultimately determines the cific cell cycle proteins are expressed in glomerular disgrowth response to injury. ease; (b) the role of cell cycle proteins in glomerular Over the past decade, particularly the past few years, cell proliferation, hypertrophy, and differentiation; (c) three paradigms have emerged in the study of the cell whether or not these findings are specific to glomerular cycle. First, each phase of the cell cycle serves a specific cells and how they differ from nonrenal cells; (d) adaptfunction in preparing the cell to proliferate [1] . Thus, in ing what has been learned in renal and nonrenal cell G 0 phase of the cell cycle, cells such as normal glomerular culture studies to experimental and human glomerular cells are quiescent [2] . Proliferation requires that cells disease; and (e) satisfying the ultimate goal, which is to engage the cell cycle at early G 1 and progress through identify specific cell cycle proteins as therapeutic targets and complete each phase of the cell cycle. In preparing in glomerular disease. the cell to proliferate, protein synthesis increases in G 1 . DNA synthesis occurs in the S phase, and cells undergo
MESANGIAL CELL PROLIFERATION
There is now abundant evidence to show that cell proliferation is central to several types of glomerular Fig. 1 . Phases of the cell cycle. The cell cycle is divided into the G 0 (quiescent), S (DNA synthesis), and M (mitosis) phases, which are separated by the resting phases called G 1 and G 2 . Proliferation requires that cells progress through the cell cycle. Arrest in G 1 can result in inhibition of proliferation or, under different circumstances, hypertrophy. Exit from the cell cycle in late G 1 results in apoptosis, whereas cells exit in G 2 to undergo differentiation.
Fig. 2. Cell cycle regulatory proteins.
Progression through each phase of the cell cycle requires that the positive cell cycle proteins cyclins bind to and activate a specific cyclin-dependent kinase (CDK). In contrast, proliferation is inhibited by negative cell cycle proteins called cyclin kinase inhibitors. The INK4 inhibitors are restricted to G 1 cyclin-CDK complexes, whereas the CIP/KIP inhibitors inhibit G1 and S phase cyclin-CDK complexes.
experimental nephrologists. A characteristic response to lonephritis (Thy1 model) is induced by an antibody directed against the Thy1 antigen normally present on rat immune [IgA nephropathy, mesangial proliferative glomerulonephritis (MPGN), lupus nephritis] and nonimmesangial cells, which results in a complement-dependent injury to the mesangial cell (mesangiolysis) [19, 20] . mune (remnant kidney)-mediated glomerular injury is mesangial cell proliferation [10] . The importance of mesThis is followed by a phase of marked mesangial cell proliferation, which precedes and is closely associated angial cell proliferation has been shown in experimental and human glomerular disease, where mesangial cell prowith the development of matrix accumulation and a decline in renal function [13] . The Thy1 model of mesangial liferation precedes and often predicts increased mesangial matrix production [11] . Moreover, maneuvers that proliferative glomerulonephritis is therefore a very useful model to further our understanding of the mechareduce mesangial cell proliferation such as low-protein diet [12] , complement depletion [13, 14] , blocking the nisms underlying the mesangial cell's proliferative response to injury. cytokines platelet-derived growth factor (PDGF) [15] , basic fibroblast growth factor (bFGF), and heparin [16] ,
The onset of mesangial cell proliferation in Thy1 glomerulonephritis is associated with a significant increase inhibiting the PDGF receptor with trapidil [17] , and inhibiting specific intracellular signaling pathways with in immunostaining for cyclin A [21] . The catalytic partner of cyclin A is CDK2, which is required and essential for phosphodiesterase inhibitors [18] have also been associated with the reduction in mesangial matrix production.
DNA synthesis [22, 23] . In contrast to quiescent nonrenal cells where CDK2 is normally constitutively expressed However, we have focused on the role of cell cycle proteins in mesangial cell proliferation because of the comthroughout the cell cycle, CDK2 immunostaining was absent in the normal quiescent rat glomerulus [21] . Howpelling view that cell proliferation is ultimately controlled in the nucleus by these proteins.
ever, mesangial cell proliferation in experimental glomerulonephritis is associated with a marked increase Cyclins and cyclin-dependent kinases in mesangialin glomerular immunostaining for CDK2, and double cell proliferation immunostaining with cell-specific markers showed that CDK2 localizes to mesangial cells [21] . To show that We began our studies by examining the expression of specific cell cycle proteins in experimental glomerular CDK2 was functionally active, glomeruli were isolated from Thy1 animals, and protein was extracted to measure disease. Experimental mesangial proliferative glomeru-CDK2 activity by the histone H1 kinase assay. Our data protein. Furthermore, decreasing CDK2 activity profoundly inhibited glomerular cell proliferation, which showed that CDK2 activity was markedly increased during mesangial cell proliferation in vivo [21] . In other was associated with an improvement in renal function. With newer and more potent pharmacological agents experimental models associated with mesangial cell proliferation such as the remnant kidney model [24], CDK2 being developed that target specific cell cycle proteins, CDK2 should be considered as a potential therapeutic protein is also increased. More recently, we have shown that CDK2 immunostaining is also increased during the target for inflammatory diseases characterized by proliferation. proliferative phase following endothelial cell injury in experimental thrombotic microangiopathy (unpublished Cyclin kinase inhibitors in glomerular data). Moreover, CDK2 protein and activity are also cell proliferation increased during growth factor-induced mesangial cell proliferation in vitro [25, 26] .
Cyclin kinase inhibitors (CKIs) inhibit cell proliferation by binding to and inactivating specific cyclin-CDK Showing that both the expression and activity for CDK2 were increased in experimental glomerulonephricomplexes [8, 30, 31] . There are two families of CKIs that are based on sequence homology and the phase of tis suggested that this cell cycle protein may be a potential target for therapeutic intervention in diseases characterthe cell cycle in which they inhibit cyclin-CDK complexes (Fig. 2) . We have focused on the Cip/Kip family of CKIs, ized by mesangial cell proliferation. To this end, we studied the purine analogue roscovitine [27] [28] [29] and showed which includes p21, p27, and p57, because these CKIs inhibit early G 1 (d-type cyclin-CDK4, 6), late G 1 (cyclin that roscovitine causes a dose-dependent reduction in CDK2 activity without altering CDK2 proteins levels E-CDK2), and S-phase (cyclin A-CDK2) cyclin-CDK complexes. What has become increasingly evident is that in cultured mesangial cells [26] . Furthermore, inhibiting CDK2 activity by roscovitine completely abrogated the distribution and function of these CKIs are not predictable or expected and are cell-type specific. There is growth factor-induced mesangial cell proliferation in vitro [26] . To determine the role of CDK2 in mesangial a differential expression of CKIs in the normal quiescent glomerulus. Immunostaining for p21 is absent in normal cell proliferation in vivo, roscovitine was given as daily intraperitoneal injections to Thy1 animals, which reglomeruli, whereas p27 is constitutively expressed in all three resident glomerular cell types [21] . In contrast, sulted in a significant reduction in the glomerular activity for CDK2 compared with control animals. Importantly, immunostaining for p57 Kip2 (p57) localizes exclusively to glomerular epithelial cells (GECs; podocytes). roscovitine did not interfere with the binding of Thy1 antibody, complement activation, or the influx of infilSimilar to what has been shown in the mesangial cell in vitro [32] , mesangial cell proliferation in vivo in the trating cells such as macrophages and platelets during the early phase of inflammation. Our results showed that Thy1 model is associated with a marked decrease in levels for p27 [32] . Moreover, by day 5, which is the peak the early decrease in CDK2 activity was associated with a marked reduction in the peak (day 5) of mesangial cell of mesangial cell proliferation in this model, p27 levels are barely detectable. However, during the recovery proliferation and glomerular cellularity in Thy1 nephritis [26] .
phase of mesangial cell injury, where proliferation ceases, p27 levels returned to baseline. Of note is that As discussed earlier, previous studies have established a relationship between mesangial cell proliferation and the decrease in levels of p27 during mesangial cell proliferation was not a predictable finding because p27 levels matrix production [9] . Our results showed that the decrease in mesangial cell proliferation induced by roscoviremain unchanged during proliferation in other cell types such as vascular smooth muscle cells (M. Reidy, personal tine was also associated with a significant decrease in the extracellular matrix proteins collagen type IV, laminin, communication). In contrast to p27, there is de novo synthesis of the and fibronectin [26] . Moreover, renal function was significantly improved compared with control animals.
CKI p21 Cip1,WAF1 (p21) during Thy1 glomerulonephritis, and double immunostaining showed that p21 localized What happens if CDK2 activity is inhibited once mesangial cell proliferation has already been established rather to mesangial cells [32] . Furthermore, the increase in p21 expression coincided with the resolution phase of mesanthan prior to the onset of proliferation? To answer this, Thy1 rats were given roscovitine starting at day 3 when gial cell proliferation in this model. Further studies are being undertaken to determine whether this CKI is reproliferating cell nuclear antigen and BrdU, markers of DNA synthesis, were already increased. When given quired for the resolution of mesangial cell proliferation in disease. under these conditions, roscovitine also significantly reduced mesangial cell proliferation at later time points in
We have used a genetic approach to establish the functional role of p27 in glomerular cell proliferation. ExperiThy1 [26] .
These studies demonstrated that CDK2 activity could mental glomerulonephritis was induced in p27 wild-type (ϩ/ϩ) and p27 knockout (Ϫ/Ϫ) mice [33] , and the study be inhibited in vivo without altering the level of the cell proliferation requires an increase in expression and activity of the positive cell cycle proteins cyclin A-CDK2. However, the onset and magnitude of mesangial cell proliferation are determined by the CKI p27, which supports the idea that p27 sets the threshold at which proliferation occurs.
VISCERAL GLOMERULAR EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION Glomerular epithelial cells exit the cell cycle during glomerulogenesis
The mature visceral GEC or podocyte is a unique glomerular cell because its growth response to injury differs from the mesangial and endothelial cells by virtue of its apparent inability to proliferate [34] . However, in contrast to mature GECs, immature GECs proliferate during specific stages of glomerulogenesis [35] . Thus, during the S-shaped stage, undifferentiated glomerular cells that transform into GECs are characterized by marked proliferation. However, during the comma stage of glomerular development, GECs exit the cell cycle and become terminally differentiated (Fig. 1) , a phenotype that is quiescent. during glomerulogenesis was due to specific CKIs. To
The levels of the cyclin kinase inhibitor p27 determine the proliferative test this hypothesis, we studied human glomerulogenesis threshold so that proliferation is augmented when p27 levels decrease. The resolution of proliferation requires a decrease in CDK2 activity, in which both proliferating and nonproliferating cell popwhich may be due to a decrease in cyclin A and CDK2 expression and/ ulations can easily be identified in the same kidney. Imor an increase in levels of the p21 and p27. munostaining for the CKI p27 was absent in proliferating immature cells that become GECs during the S-shaped stage of glomerular development. In contrast, the cessashowed three findings. First, under normal physiological tion of GEC proliferation that accompanies GEC exit conditions, the loss of p27 by itself was not associated from the cell cycle coincided with the de novo expression with ongoing DNA synthesis in adolescent p27Ϫ/Ϫ of p27 [36] . These results suggest that p27 may be remouse kidneys. Second, during inflammatory glomeruloquired for normal GEC differentiation. nephritis, the onset of glomerular cell DNA synthesis and What about the expression of other CKIs during GEC proliferation occurred at earlier time points in p27Ϫ/Ϫ development? p57 is also expressed de novo in GECs mice compared with controls. Third, in glomerulonephriduring mouse and rat glomerulogenesis. A role for p57 in tis, the magnitude of glomerular DNA synthesis and GEC biology has been shown in genetic studies. Animals proliferation was markedly increased at all time points that lack p57 (p57 knockout mice) are born with fused studied in p27Ϫ/Ϫ mice compared with controls. To enfoot processes and have many features that resemble sure that the increase in glomerular cell proliferation in Beckwith-Wederman syndrome [37] . These studies sugp27Ϫ/Ϫ mice was not due to a difference in immunegest that p57 may be required for normal GEC developresponse, p27ϩ/ϩ and p27Ϫ/Ϫ mice underwent total ment. In contrast, mice lacking the CKI p21 (p27Ϫ/Ϫ body irradiation, and the bone marrow was reconstituted mice) have normal kidneys, suggesting that p21 is not with marrow from normal p27ϩ/ϩ mice. Experimental essential for normal GEC differentiation. Taken toglomerulonephritis was then induced in both groups of gether, specific CKIs may be essential for the developmarrow-transplanted mice. The results confirmed that ment of the quiescent differentiated GEC phenotype. glomerular cell proliferation was increased in nephritic p27Ϫ/Ϫ mice compared with controls, and also demonInability of mature differentiated glomerular epithelial strated that the levels of p27 in the glomerulus rather cell proliferation than the immune response determine the proliferative Although there is some debate regarding the proliferaresponse to injury.
tive capacity of mature GECs, most studies have shown A summary of the role for cell cycle proteins in mesangial cell proliferation is shown in Figure 3 . Mesangial that in striking contrast to mesangial and endothelial cells, GEC proliferation is not marked. However, under of both p21 and p27 to cyclin A-CDK2 complexes in PHN rats compared with controls. Moreover, p21 and certain circumstances, GECs do re-enter the cell cycle and undergo DNA synthesis, albeit low grade compared p27 inhibited the activity of CDK2 and thereby limited DNA synthesis [45] . with mesangial cells, and proliferate [38] . However, the current paradigm is that the relative inability of the The cytokine basic fibroblast growth factor (bFGF) is a mitogen for GECs in vitro [46] , and giving bFGF to GECs to proliferate may underlie the development of glomerular sclerosis in many forms of injury to the GECs passive Heyman's nephritis (PHN) rats increases DNA synthesis in GECs [47] . To determine if the increase in [34, 39, 40] .
Many differentiated cells can re-engage the cell cycle GEC DNA synthesis was due to an increase in positive cell cycle proteins or a decrease in negative cell cycle under certain cues. Why then do mature GECs not proliferate? One thesis is that terminally differentiated GECs proteins, bFGF was given to PHN rats [45] . The expression for CDK2 was not altered by bFGF. However, bFGF lack certain positive cell cycle (cyclins and CDKs) proteins required to progress through the cell cycle. Another caused a differential down-regulation in CKI expression in PHN. The expression for the CKI p15 and p27 was possibility is that the levels of negative cell cycle proteins (CKIs) increase. To address these possibilities, we studunchanged. In contrast, bFGF caused a marked and selective decrease in p21 levels that coincided with inied the passive Heymann nephritis (PHN) model of membranous nephropathy, which is induced by the adcreased DNA synthesis. These results showed that the increase in the CKIs p21 and p27 may be responsible for ministration of an antibody to the anti-Fx1A antigen on the GECs, resulting in a complement-dependent injury limiting DNA synthesis in the GECs following immunemediated injury and that lowering the levels of p21 was to GECs [41, 42] . This is followed by the formation of subepithelial immune deposits, foot process fusion and required for DNA synthesis.
To determine the functional role for p21 in GEC proeffacement, and proteinuria. In contrast to the increase in mesangial cell number following complement-induced liferation, experimental glomerulonephritis was induced injury to the mesangial cell, the GEC number is normal in p21 knockout mice and control p21 wild-type mice in experimental membranous nephropathy [43] . Studies (see Note Added in Proof, number 1). A striking finding have shown that this is due to an apparent inability of was that GEC DNA synthesis was markedly increased GECs to proliferate. The significance of the apparent in nephritic p21Ϫ/Ϫ mice compared with controls. Moreinability of GECs to proliferate has been proposed by over, GEC proliferation was also increased, and this Kriz and Rennke [34, 39, 44 ] to involve the inability of was associated with increased matrix production and a GECs to replace injured and lost GECs leading to a marked decline in renal function compared with controls. denuded glomerular basement membrane, which under- Figure 4 summarizes our current thinking regarding lies the development of progressive glomerulosclerosis.
the role of CKI in GEC biology. GEC exit from the cell To determine if the inability of GECs to proliferate cycle during glomerulogenesis coincides with the de novo is due to the lack of cell cycle proteins required for DNA expression of the CKI p27 and p57. It is very tempting synthesis, the expression for cyclin A and CDK2 was to speculate that these specific cell cycle proteins are measured. Complement-dependent GEC injury in PHN required for GEC differentiation. In the mature quieswas followed by a small but significant increase in immucent GEC, the levels of CKI determine the proliferative nostaining for cyclin A and CDK2, and this localized to capacity of GECs rather than the inability of GECs to GECs [45] . These results suggested that GECs have the increase and activate cell cycle proteins required for "nuclear machinery" required for DNA synthesis and DNA synthesis. Thus, if the levels of p21 and p27 inthat the apparent lack of proliferation was likely not crease in diseases such as membranous nephropathy, entirely due to the inability to increase cyclin A and GECs do not proliferate. In contrast, if p21 or p27 levels CDK2.
decrease following injury, GECs re-engage the cell cycle What about the role of CKIs in membranous nephropand undergo a marked increase in DNA synthesis and athy? In contrast to a decrease in p27 levels in immuneproliferation. mediated injury to mesangial cells in Thy1 [21], immunemediated injury to GECs in membranous nephropathy GLOMERULAR HYPERTROPHY was associated with a marked increase in immunostainIn contrast to the marked mesangial cell proliferation ing for the CKIs p21 and p27 [45] . Cell-type-specific that follows many forms of immune-and nonimmunemarkers showed that increased p21 and p27 staining lomediated glomerular injury, the predominant growth recalized to GECs. To show that these CKIs where responsponse by the mesangial cell in diabetic nephropathy is sible for limiting DNA synthesis in GECs, protein was hypertrophy [48] [49] [50] . There is also a decrease in GEC extracted from isolated glomeruli from PHN rats, and number in human diabetic nephropathy [51] . co-immunoprecipitation studies were performed. The results showed that there was an increase in the binding When a cell engages the cell cycle at the early G 1 Fig. 4 . Proposed schema for visceral glomerular epithelial cell (GEC) proliferation and differentiation. During glomerulogenesis, proliferating GECs exit from the cell cycle coincides with the de novo expression of the cyclin kinase inhibitors (CKI) p27 and p57 and the development of a terminally differentiated phenotype. The levels of CKI determine the proliferative response of mature GECs to injury. An increase in p21 and p27 maintains a terminally differentiated phenotype where GEC proliferation is limited. In contrast, lowering p21 and p27 levels is associated with a dedifferentiated phenotype, which proliferates.
Fig. 5. Diabetic glomerular hypertrophy.
The proposed schema shows that diabetic glomerular hypertrophy is due to increased levels of the cyclin kinase inhibitors p21 and p27. Hyperglycemia increases p21 and p27 levels, which block DNA synthesis in the setting where protein is increased, thus leading to hypertrophy (defined as an increase in protein to DNA ratio). Reducing levels of these cyclin kinase inhibitors attenuates diabetic glomerular hypertrophy, despite an increase in transforming growth factor-␤1.
phase, there is an increase in protein content. Because and A and CDK2 could not be detected in the rat [54] and mouse [53] streptozotocin models of diabetic neof the absence of DNA synthesis during the G 1 phase of the cell cycle, the ratio of protein to DNA is physiologphropathy.
In contrast to the expression of cyclins and CDKs, ically increased (Fig. 1) . Hypertrophy is defined as a pathological increase in protein to DNA ratio [3, 52] .
glucose-induced mesangial cell hypertrophy in vitro is associated with a marked increase in levels for the CKIs Thus, we and others have developed the hypothesis that hypertrophy may be due to an increase in CKIs.
p21 hypertrophy is summarized in Figure 5 . 65:601-605, 1991 In summary, the role of the cell cycle regulatory pro- 
